Skin Diseases, Infectious Clinical Trial
Official title:
A Phase III, Randomized, Double-Blind Study of Ceftobiprole Versus Comparator in the Treatment of Complicated Skin and Skin Structure Infections
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections.
Ceftobiprole medocaril is a cephalosporin antibiotic with anti-MRSA (Methicillin-Resistant Staphylococcus Aureus) activity. Ceftobiprole medocaril is not yet approved for the treatment of complicated skin and skin structure infections. This is a randomized, double-blind, multicenter study of ceftobiprole medocaril plus placebo versus a comparator to assess the effectiveness and safety of ceftobiprole medocaril in patients with complicated skin and skin structure infections. The patients will be randomized to ceftobiprole medocaril plus placebo or a comparator. The primary endpoint is the clinical cure rate of ceftobiprole medocaril at the test-of-cure visit. The patients will receive either ceftobiprole medocaril plus placebo or a comparator for 7 to 14 days (unless extended at discretion of medical monitor). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00746109 -
Study of Wound Packing After Superficial Skin Abscess Drainage
|
Phase 4 | |
| Completed |
NCT00210899 -
Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
|
Phase 3 | |
| Completed |
NCT00761215 -
Phase 2 Study of TR-701 in Patients With Complicated Skin and Skin Structure Infections
|
Phase 2 | |
| Completed |
NCT01967225 -
Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
|
Phase 3 | |
| Withdrawn |
NCT00990392 -
Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections
|
N/A | |
| Completed |
NCT00228410 -
Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections
|
Phase 3 | |
| Completed |
NCT05608382 -
Effect of an Antiseptic Solution on the Skin Microbiome
|
N/A | |
| Completed |
NCT03487549 -
Cantharidin and Occlusion in Verruca Epithelium
|
Phase 2 | |
| Completed |
NCT02276482 -
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
|
Phase 3 | |
| Completed |
NCT00198679 -
Effect of Chlorhexidine Skin Cleansing on Skin Flora
|
Phase 4 | |
| Completed |
NCT03981822 -
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
|
Phase 2 | |
| Completed |
NCT00711802 -
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
|
Phase 4 | |
| Completed |
NCT00488761 -
Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
|
Phase 4 | |
| Completed |
NCT00679302 -
Utility of Trimethoprim-sulfamethoxazole Use in Skin Abscess Management
|
Phase 4 | |
| Completed |
NCT00257036 -
A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Mild to Moderate Infections of the Skin and the Supportive Layers Beneath the Skin
|
Phase 2/Phase 3 | |
| Completed |
NCT04485676 -
Dalbavancin in Real Clinical Practice in Spain
|
||
| Completed |
NCT00785200 -
MRSA Colonization and Control in the Dallas County Jail
|
N/A | |
| Completed |
NCT00257062 -
A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin
|
Phase 3 | |
| Completed |
NCT02582203 -
Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
|
Phase 4 | |
| Completed |
NCT00388310 -
Effective Antibiotic Treatment of MRSA
|
N/A |